While France has revoked the derogatory decree authorizing hydroxychloroquine prescription against coronavirus, excluding clinical trials, Professor Didier Raoult sticks to it. “We’ll keep on treating our patients with the most fitted treatments given the current state of science and knowledge” the IHU Méditerranée said this Wednesday May 27. That is to say, they will keep on giving hydroxychloroquine against Covid-19.
A statement, but also a decree that comes right after medical magazine The Lancet released a study about the use of hydroxychloroquine and its dangerousness to treat coronavirus. A study that heads in the same direction as several other American, French, or even Chinese clinical trials as they have also called out the medicine. A study that Professor Raoult cast doubt on, saying it is “crap”.
“We’ve had 4,000 patients, so, don’t believe I will change because there are people making of big data a sort of completely delirious fantasy” he said. He went on by saying he does not trust researches involving “big data” that “takes data we don’t know the quality of, that mixes everything, mixes treatments we don’t know what dose has been given”. A medication that will spark debates for a while.
